Hakutulokset - Arlene Naranjo

Tarkenna hakua
  1. 1
    The ganglioside G<sub>D2</sub> as a circulating tumor biomarker for neuroblastoma

    The ganglioside G<sub>D2</sub> as a circulating tumor biomarker for neuroblastoma Tekijä Frank M. Balis, Christine M. Busch, Ami V. Desai, Emily Hibbitts, Arlene Naranjo, Rochelle Bagatell, Meredith S. Irwin, Elizabeth Fox

    Julkaistu 2019
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Tailoring Therapy for Children With Neuroblastoma on the Basis of Risk Group Classification: Past, Present, and Future

    Tailoring Therapy for Children With Neuroblastoma on the Basis of Risk Group Classification: Past, Present, and Future Tekijä Wayne H. Liang, Sara M. Federico, Wendy B. London, Arlene Naranjo, Meredith S. Irwin, Samuel L. Volchenboum, Susan L. Cohn

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Children's Oncology Group's 2023 blueprint for research: Neuroblastoma

    Children's Oncology Group's 2023 blueprint for research: Neuroblastoma Tekijä Rochelle Bagatell, Steven G. DuBois, Arlene Naranjo, J. S. Van Belle, Kelly C. Goldsmith, Julie R. Park, Meredith S. Irwin

    Julkaistu 2023
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    Historical time to disease progression and progression‐free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early‐phase trials

    Historical time to disease progression and progression‐free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group earl... Tekijä Wendy B. London, Rochelle Bagatell, Brenda J. Weigel, Elizabeth Fox, Dongjing Guo, Collin Van Ryn, Arlene Naranjo, Julie R. Park

    Julkaistu 2017
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Characterization of adolescent and pediatric renal cell carcinoma: A report from the Children's Oncology Group study AREN03B2

    Characterization of adolescent and pediatric renal cell carcinoma: A report from the Children's Oncology Group study AREN03B2 Tekijä James I. Geller, Peter F. Ehrlich, Nicholas G. Cost, Geetika Khanna, Elizabeth A. Mullen, Eric J. Gratias, Arlene Naranjo, Jeffrey S. Dome, Elizabeth J. Perlman

    Julkaistu 2015
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    Comparison of diagnostic performance of CT and MRI for abdominal staging of pediatric renal tumors: a report from the Children’s Oncology Group

    Comparison of diagnostic performance of CT and MRI for abdominal staging of pediatric renal tumors: a report from the Children’s Oncology Group Tekijä Sabah Servaes, Geetika Khanna, Arlene Naranjo, James I. Geller, Peter F. Ehrlich, Kenneth W. Gow, Elizabeth J. Perlman, Jeffrey S. Dome, Eric J. Gratias, Elizabeth A. Mullen

    Julkaistu 2014
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    Pilot Induction Regimen Incorporating Pharmacokinetically Guided Topotecan for Treatment of Newly Diagnosed High-Risk Neuroblastoma: A Children's Oncology Group Study

    Pilot Induction Regimen Incorporating Pharmacokinetically Guided Topotecan for Treatment of Newly Diagnosed High-Risk Neuroblastoma: A Children's Oncology Group Study Tekijä Julie R. Park, Jeffrey R. Scott, Clinton F. Stewart, Wendy B. London, Arlene Naranjo, Victor M. Santana, Peter J. Shaw, Susan L. Cohn, Katherine K. Matthay

    Julkaistu 2011
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Predictors of differential response to induction therapy in high-risk neuroblastoma: A report from the Children's Oncology Group (COG)

    Predictors of differential response to induction therapy in high-risk neuroblastoma: A report from the Children's Oncology Group (COG) Tekijä Navin Pinto, Arlene Naranjo, Emily Hibbitts, Susan G. Kreissman, Meaghan Granger, Meredith S. Irwin, Rochelle Bagatell, Wendy B. London, Emily Greengard, Julie R. Park, Steven G. DuBois

    Julkaistu 2019
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    Detection of Preoperative Wilms Tumor Rupture with CT: A Report from the Children’s Oncology Group

    Detection of Preoperative Wilms Tumor Rupture with CT: A Report from the Children’s Oncology Group Tekijä Geetika Khanna, Arlene Naranjo, Fredric A. Hoffer, Elizabeth A. Mullen, James I. Geller, Eric J. Gratias, Peter F. Ehrlich, Elizabeth J. Perlman, Nancy Rosen, Paul E. Grundy, Jeffrey S. Dome

    Julkaistu 2012
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial

    Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomis... Tekijä Pedro A. de Alarcón, Katherine K. Matthay, Wendy B. London, Arlene Naranjo, Sheena C. Tenney, Jessica A. Panzer, Michael D. Hogarty, Julie R. Park, John M. Maris, Susan L. Cohn

    Julkaistu 2017
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    Poverty and Targeted Immunotherapy: Survival in Children’s Oncology Group Clinical Trials for High-Risk Neuroblastoma

    Poverty and Targeted Immunotherapy: Survival in Children’s Oncology Group Clinical Trials for High-Risk Neuroblastoma Tekijä Kira Bona, Yimei Li, Lena E. Winestone, Kelly Getz, Yuan‐Shung Huang, Brian T. Fisher, Ami V. Desai, Troy Richardson, Matt Hall, Arlene Naranjo, Tara O. Henderson, Richard Aplenc, Rochelle Bagatell

    Julkaistu 2020
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    A Prospective Study of Expectant Observation as Primary Therapy for Neuroblastoma in Young Infants

    A Prospective Study of Expectant Observation as Primary Therapy for Neuroblastoma in Young Infants Tekijä Jed G. Nuchtern, Wendy B. London, Carol E. Barnewolt, Arlene Naranjo, Patrick McGrady, James D. Geiger, Lisa Diller, Mary Lou Schmidt, John M. Maris, Susan L. Cohn, Robert C. Shamberger

    Julkaistu 2012
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    Semiquantitative mIBG Scoring as a Prognostic Indicator in Patients with Stage 4 Neuroblastoma: A Report from the Children’s Oncology Group

    Semiquantitative mIBG Scoring as a Prognostic Indicator in Patients with Stage 4 Neuroblastoma: A Report from the Children’s Oncology Group Tekijä Gregory A. Yanik, Marguerite T. Parisi, Barry L. Shulkin, Arlene Naranjo, Susan G. Kreissman, Wendy B. London, Judith G. Villablanca, John M. Maris, Julie R. Park, Susan L. Cohn, Patrick McGrady, Katherine K. Matthay

    Julkaistu 2013
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  14. 14
    Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children’s Oncology Group Study ANBL0531

    Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children’s Oncology Group Study ANBL0531 Tekijä Clare J. Twist, Arlene Naranjo, Mary Lou Schmidt, Sheena C. Tenney, Susan L. Cohn, Holly J. Meany, Peter Mattei, E. Stanton Adkins, Hiroyuki Shimada, Wendy B. London, Julie R. Park, Katherine K. Matthay, John M. Maris

    Julkaistu 2018
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  15. 15
    Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project

    Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project Tekijä Elizabeth Sokol, Ami V. Desai, Mark A. Applebaum, Dominique Valteau‐Couanet, Julie R. Park, Andrew D.J. Pearson, Gudrun Schleiermacher, Meredith S. Irwin, Michael D. Hogarty, Arlene Naranjo, Samuel L. Volchenboum, Susan L. Cohn, Wendy B. London

    Julkaistu 2020
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  16. 16
    Children's Oncology Group's 2013 blueprint for research: Renal tumors

    Children's Oncology Group's 2013 blueprint for research: Renal tumors Tekijä Jeffrey S. Dome, Conrad V. Fernandez, Elizabeth A. Mullen, John A. Kalapurakal, James I. Geller, Vicki Huff, Eric J. Gratias, David Dix, Peter F. Ehrlich, Geetika Khanna, Marcio H. Malogolowkin, James R. Anderson, Arlene Naranjo, Elizabeth J. Perlman

    Julkaistu 2012
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  17. 17
    Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: A report from the CCG and COG

    Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: A report from the CCG and COG Tekijä Chizuko Okamatsu, Wendy B. London, Arlene Naranjo, Michael D. Hogarty, Julie M. Gastier‐Foster, A. Thomas Look, Michael P. LaQuaglia, John M. Maris, Susan L. Cohn, Katherine K. Matthay, Robert C. Seeger, Tsutomu Saji, Hiroyuki Shimada

    Julkaistu 2009
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  18. 18
    A pilot study of tandem high-dose chemotherapy with stem cell rescue as consolidation for high-risk neuroblastoma: Children’s Oncology Group study ANBL00P1

    A pilot study of tandem high-dose chemotherapy with stem cell rescue as consolidation for high-risk neuroblastoma: Children’s Oncology Group study ANBL00P1 Tekijä Alix E. Seif, Arlene Naranjo, David L. Baker, Nancy Bunin, Morris Kletzel, C. Kretschmar, John M. Maris, Patrick McGrady, Daniel von Allmen, Susan L. Cohn, Wendy B. London, J R Park, Lisa Diller, Stephan A. Grupp

    Julkaistu 2013
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  19. 19
    Association of <i>MYCN</i> copy number with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group

    Association of <i>MYCN</i> copy number with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group Tekijä Kevin Campbell, Julie M. Gastier‐Foster, Meegan Mann, Arlene Naranjo, Collin Van Ryn, Rochelle Bagatell, Katherine K. Matthay, Wendy B. London, Meredith S. Irwin, Hiroyuki Shimada, Meaghan Granger, Michael D. Hogarty, Julie R. Park, Steven G. DuBois

    Julkaistu 2017
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  20. 20
    Racial and Ethnic Survival Disparities Among Children With High-Risk Neuroblastoma

    Racial and Ethnic Survival Disparities Among Children With High-Risk Neuroblastoma Tekijä Puja J. Umaretiya, Arlene Naranjo, Fan F. Zhang, Julie R. Park, Brian Weiss, Meaghan Granger, Ami V. Desai, M. Fevzi Özkaynak, Alice L. Yu, Rahela Aziz‐Bose, Sandi L. Pruitt, Steven G. DuBois, Rochelle Bagatell, Kira Bona

    Julkaistu 2025
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: